At presently, GSK has its own nicotine replacement patch, Nicoderm CQ, a direct competitor of Habitrol
The contest is funded by the Government of Ontario with prize support provided by the makers of Thrive and Habitrol
2) Transdermal patch formulation previously marketed as Habitrol
There's the V-Chip, the Habitrol
nicotine patch, an electronic hearing implant, and Google.
The plaintiff's federal appellate brief in a Habitrol
case where the Oklahoma trial court held that that an exception to the learned intermediary rule exists where the FDA requires direct consumer warnings on prescription products.
TABLE Transdermal Patch Comparison Dosage Trade Names Dosing Forms Available Habitrol
21 mg/day for 4 weeks, then 7,14, and 21 14 mg/day for 2 weeks, then mg/day patches 7 mg/day for 2 weeks Nicoderm, 21 mg/day for 6 weeks, then 7, 14, and 21 Nicoderm CQ 14 mg/day for 2 weeks, then mg/day patches Clear Nicoderm 7 mg/day for 2 weeks CQ Nicotrol 15 mg/16 hrs for 6 weeks 15 mg/16 hrs patch
Following the plaintiff's reasoning, the Oklahoma Supreme Court held that the FDA mandate of a direct patient warning created an exception to the learned intermediary doctrine, and imposed a common law duty on the Habitrol
manufacturer to provide an adequate warning to the patient directly.
Novartis has decided to divest Habitrol
, its private label nicotine replacement therapy (NRT) transdermal patch business in the US, which was laid as a condition to gain FTC approval for the consumer healthcare JV.
These breakthroughs include the development of the Google search engine, Habitrol
Nicotine patch, treatments for neglected diseases, cancer drug Taxol, and the V-chip -- all of which might not exist today if not for the support of academic technology transfer.
Sponsorship tools available to physicians on the Web include a smoking-cessation support program from Novartis, maker of the Habitrol
In addition to a personal coach, the program features customized programming, support and education and discounts for supportive programs such as Weight Watchers and Habitrol
Nicotine Replacement Therapy.
The company also signed an agreement for Tobacco Solutions, an eight-week tobacco cessation program offering deep discounts on the Novartis Habitrol
Transdermal system, "the patch," and behavioral support through educational materials and toll-free counseling support five days a week.